Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Imaging and symptom rating scales offer physicians ample opportunity to follow patients with ...

Neil is KSBY's Senior Reporter and anchor of KSBY News Daybreak. He's one of your dedicated community reporters for the City of San Luis Obispo. Myositis is a debilitating disease that causes ...

CHARLESTON, S.C. (WCSC) - One man is making it his mission to cross off his bucket list while bringing awareness to a rare medical diagnosis. Chip Galloway was diagnosed with Inclusion Body Myositis, ...

Sporadic inclusion body myositis (sIBM) presents with a characteristic clinical phenotype of slow-onset weakness and atrophy, affecting proximal and distal limb muscles and facial and pharyngeal ...

Early-onset IBM challenges age-centric diagnostic criteria, with symptoms appearing in patients younger than 46. Younger IBM patients show a higher rate of mitochondrial DNA mutations, indicating ...

Peter Frampton hopes fans "appreciate the fact that I’m not giving up." The legendary singer and songwriter, 74, tells PEOPLE that he's a "fighter" and will continue performing and making music for as ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Although new targets and therapies are on the horizon, current myositis treatment strategies rely ...

NEWTON, Mass., March 26, 2026--(BUSINESS WIRE)--Abcuro, Inc., a clinical stage biotechnology company, today presented results at the 6 th Global Conference on Myositis (GCOM) meeting, being held March ...

Idiopathic inflammatory myopathies (IIMs) comprise a group of inflammatory disorders in which there is chronic inflammation of skeletal muscle. This is then followed by muscle weakness. One type of ...

NEWTON, Mass.--(BUSINESS WIRE)--Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T ...

NEWTON, Mass.--(BUSINESS WIRE)--Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T ...

sIBM is a complex disorder, the underlying cause of which is unclear. The observation that the intact muscle fibers are invaded by T lymphocytes, whereas the vacuolated fibers lack T-cell autoinvasion ...